Abstract:Macrocyclic peptides are predominantly peptide structures bearing one or more rings and spanning multiple amino acid residues. Macrocyclization has become a common approach for improving the pharmacological properties and bioactivity of peptides. A variety of ribosomal-derived and non-ribosomal synthesized cyclization approaches have been established. The biosynthesis of backbone macrocyclic peptides using seven new emerging methodologies will be discussed with regard to the features and strengths of each platform rather than medicinal chemistry tools. The mRNA display variant, known as the random nonstandard peptide integrated discovery (RaPID) platform, utilizes flexible in vitro translation (FIT) to access macrocyclic peptides containing nonproteinogenic amino acids (NAAs). As a new discovery approach, the ribosomally synthesized and post-translationally modified peptides (RiPPs) method involves the combination of ribosomal synthesis and the phage screening platform together with macrocyclization chemistries to generate libraries of macrocyclic peptides. Meanwhile, the split-intein circular ligation of peptides and proteins (SICLOPPS) approach relies on the in vivo production of macrocyclic peptides. In vitro and in vivo peptide library screening is discussed as an advanced strategy for cyclic peptide selection. Specifically, biosynthetic bicyclic peptides are highlighted as versatile and attractive modalities. Bicyclic peptides represent another type of promising therapeutics that allow for building blocks with a heterotrimeric conjugate to address intractable challenges and enable multimer complexes via linkers. Additionally, we discuss the cell-free chemoenzymatic synthesis of macrocyclic peptides with a non-ribosomal catalase known as the non-ribosomal synthetase (NRPS) and chemo-enzymatic approach, with recombinant thioesterase (TE) domains. Novel insights into the use of peptide library tools, activity-based two-hybrid screening, structure diversification, inclusion of NAAs, combinatorial libraries, expanding the toolbox for macrocyclic peptides, bicyclic peptides, chemoenzymatic strategies, and future perspectives are presented. This review highlights the broad spectrum of strategy classes, novel platforms, structure diversity, chemical space, and functionalities of macrocyclic peptides enabled by emerging biosynthetic platforms to achieve bioactivity and for therapeutic purposes.

Assembling Branched and Macrocyclic Peptides on Proteins

Reversible stapling of unprotected peptides via chemoselective methionine bis-alkylation/dealkylation.

Biocompatible Strategies for Peptide Macrocyclisation

Macrocyclic Peptide Construction Through C-H Activation Strategy.

A Sulfonium Tethered Peptide Ligand Rapidly and Selectively Modifies Protein Cysteine in Vicinity

Advancing multicomponent strategies to macrobicyclic peptides

Crafting Unnatural Peptide Macrocycles via Rh(III)-Catalyzed Carboamidation

Backbone-Enabled Peptide Macrocyclization Through Late-Stage Palladium-Catalyzed C-H Activation

Non-Symmetric Cysteine Stapling in Native Peptides and Proteins

Selective Macrocyclization of Unprotected Peptides with an Ex Situ Gaseous Linchpin Reagent

Construction of Complex Macromulticyclic Peptides via Stitching with Formaldehyde and Guanidine

Peptide Macrocyclization Through Palladium-Catalyzed Late-Stage C-H Activation.

Selective Peptide Cysteine Manipulation on Demand and Difficult Protein Chemical Synthesis Enabled by Controllable Acidolysis of N,S‐Benzylidene Thioacetals

C-Terminal Peptide Modification: Merging the Passerini Reaction with Chemo-Enzymatic Synthesis

Biosynthetic Strategies for Macrocyclic Peptides

Peptide Macrocyclization via Intramolecular Interception of Visible-Light-Mediated Desulfurization

Peptide Macrocyclisation via Intramolecular Interception of Visible-Light-Mediated Desulfurisation

Recent Advances in Peptide Macrocyclization Strategies.

Constructing Cyclic Peptides Using an On-Tether Sulfonium Center

Modular Diazo Compound for the Bioreversible Late-Stage Modification of Proteins.

Cysteine-Specific Bioconjugation and Stapling of Unprotected Peptides by Chlorooximes